Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
14.98
+0.06 (0.40%)
May 7, 2026, 11:37 AM EDT - Market open
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $425.44 million as of May 7, 2026. Its market cap has decreased by -25.24% in one year.
Market Cap
425.44M
Enterprise Value
-170.68M
1-Year Change
-25.24%
Ranking
Category
Stock Price
$14.98
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $425.44M, an increase of 171.85%. That is a compound annual growth rate of 10.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 423.70M | -47.83% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 1.16B |
| CareDx | 1.08B |
| GeneDx Holdings | 1.03B |
| OPKO Health | 845.70M |
| Castle Biosciences | 749.83M |
| Personalis | 635.39M |
| Myriad Genetics | 388.16M |
| Prenetics Global | 267.57M |